Tolterodine Tartrate/Tamsulosin Hydrochloride

酒石酸托特罗定/盐酸坦洛新

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTolterodine Tartrate/Tamsulosin Hydrochloride
Drug Alias NameTamsulosin Hydrochloride and Tolterodine Tartrate盐酸坦洛新酒石酸托特罗定酒石酸托特罗定盐酸坦洛新Tolterodine Tartrate and Tamsulosin HydrochlorideTamsulosin/Tolterodine +[10] 
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsAlpha-1a adrenergic receptor antagonists
TargetsMuscarinic acetylcholine receptorAlpha-1a adrenergic receptor
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsUrinary Bladder, Overactive
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2007/08/01
Country/TerritoryIndia
CombinationsYes Tamsulosin HydrochlorideTolterodine Tartrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBeijing Representative Office Of Ramsey Lab Co Ltd India
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Representative Office Of Ramsey Lab Co Ltd India
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, Overactive
Inactive IndicationsN/A

Other Information

ATC CodeG04BD
Related LinksN/A